Litigating the Drug Price Competition and Patent Term Restoration Act of 1984

DSpace/Manakin Repository

Litigating the Drug Price Competition and Patent Term Restoration Act of 1984

Citable link to this page

. . . . . .

Title: Litigating the Drug Price Competition and Patent Term Restoration Act of 1984
Author: Reines, Emily B.
Citation: Litigating the Drug Price Competition and Patent Term Restoration Act of 1984 (2000 Third Year Paper)
Full Text & Related Files:
Abstract: The Drug Price Competition and Patent Term Restoration Act of 1984, also known as the Hatch-Waxman Act in honor of its sponsors Senator Orrin Hatch and Representative Henry Waxman, was enacted in an attempt to reconcile two seemingly contradictory policy goals. The Act represented a compromise between the interests of generic drug manufacturers and the competing interests of the "pioneer" drug manufacturers who research and develop novel drug products. Thus, the Act was designed to improve the availability of inexpensive generic drugs, while maintaining sufficient incentives for investment in new drug development. The Hatch-Waxman Act creates a complex statutory framework, such that many problems and debates have arisen surrounding its implementation. This paper gives an overview of the issues that have been litigated under the Hatch-Waxman Act in the nearly sixteen years since its enactment.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846791

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters